drugset
drugset / Trial / NCT05158192

Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product

NCT05158192 ↗

Phase 1 Completed 12 enrolled Laboratorios Andromaco S.A.
RandomizedCrossoverOpen-labelBasic science

Summary

This Pilot study investigated the bioavailability in adult human subjects of 1 tablet formulations containing Diosmin/Hesperidin (90/10) 500 mg. The Pilot study was performed at a single site with 12 subjects. Participants took 1 tablets of the test product and reference product in 2 periods and 2 sequences (either test after reference or reference after test). There was a washout of 7 days between each study period.

Timeline

Start
2021-11-04
Primary completion
2021-12-14
Completion
2021-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Diosmin Small molecule 500 mg —

Indications

No indication recorded.